Generics Primed To Fight FDA On Labeling Flexibility
The U.S. Food and Drug Administration is considering making generic-drug makers responsible for the warnings on their product labels, but attorneys say the industry may attempt to avoid liability by attacking...To view the full article, register now.
Already a subscriber? Click here to view full article